These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32615799)

  • 1. Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework?
    Pandya A; Soeteman DI; Gupta A; Kamel H; Mushlin AI; Rosenthal MB
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006492. PubMed ID: 32615799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of financial incentives on the quality of health care provided by primary care physicians.
    Scott A; Sivey P; Ait Ouakrim D; Willenberg L; Naccarella L; Furler J; Young D
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008451. PubMed ID: 21901722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost measurement in the meaningful incentive payment system.
    Copeland TP; Woo K
    J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):551. PubMed ID: 29909862
    [No Abstract]   [Full Text] [Related]  

  • 4. Using financial incentives to improve value in orthopaedics.
    Lansky D; Nwachukwu BU; Bozic KJ
    Clin Orthop Relat Res; 2012 Apr; 470(4):1027-37. PubMed ID: 22002826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that Predict Failure to Meet Merit-Based Incentive Payment System Quality Measures for Asymptomatic Carotid Endarterectomy.
    Dua A; Koprowski S; Ali F; Desai SS
    Ann Vasc Surg; 2018 Apr; 48():127-132. PubMed ID: 29217445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incentive payments are not related to expected health gain in the pay for performance scheme for UK primary care: cross-sectional analysis.
    Fleetcroft R; Steel N; Cookson R; Walker S; Howe A
    BMC Health Serv Res; 2012 Apr; 12():94. PubMed ID: 22507660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial Incentives to Encourage Value-Based Health Care.
    Scott A; Liu M; Yong J
    Med Care Res Rev; 2018 Feb; 75(1):3-32. PubMed ID: 27815451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost, quality, and value in coronary artery bypass grafting.
    Osnabrugge RL; Speir AM; Head SJ; Jones PG; Ailawadi G; Fonner CE; Fonner E; Kappetein AP; Rich JB
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2729-35.e1. PubMed ID: 25238884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Measurement and Reward: Methods of Motivating Quality Improvement and Accountability.
    Berenson RA; Rice T
    Health Serv Res; 2015 Dec; 50 Suppl 2(Suppl 2):2155-86. PubMed ID: 26555346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
    Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
    PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pay-for-performance schemes that use patient and provider categories would reduce payment disparities.
    Damberg CL; Elliott MN; Ewing BA
    Health Aff (Millwood); 2015 Jan; 34(1):134-42. PubMed ID: 25561654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Mechanical Thrombectomy More Than 6 Hours After Symptom Onset Among Patients With Acute Ischemic Stroke.
    Peultier AC; Pandya A; Sharma R; Severens JL; Redekop WK
    JAMA Netw Open; 2020 Aug; 3(8):e2012476. PubMed ID: 32840620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke.
    Boudreau DM; Guzauskas G; Villa KF; Fagan SC; Veenstra DL
    Ann Emerg Med; 2013 Jan; 61(1):46-55. PubMed ID: 22633340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Society for Vascular Surgery Alternative Payment Model Task Force report on opportunities for value-based reimbursement in care for patients with peripheral artery disease.
    Duwayri YM; Woo K; Aiello FA; Adams JG; Ryan PC; Tracci MC; Hurie J; Davies MG; Shutze WP; McDevitt D; Lum YW; Sideman M; Zwolak RM
    J Vasc Surg; 2021 Apr; 73(4):1404-1413.e2. PubMed ID: 32931874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of tissue-type plasminogen activator in the 3- to 4.5-hour time window for acute ischemic stroke.
    Tung CE; Win SS; Lansberg MG
    Stroke; 2011 Aug; 42(8):2257-62. PubMed ID: 21719767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of optimizing acute stroke care services for thrombolysis.
    Penaloza-Ramos MC; Sheppard JP; Jowett S; Barton P; Mant J; Quinn T; Mellor RM; Sims D; Sandler D; McManus RJ;
    Stroke; 2014 Feb; 45(2):553-62. PubMed ID: 24385272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Would a Large tPA Trial for Those 4.5 to 6.0 Hours from Stroke Onset Be Good Value for Information?
    Soeteman DI; Menzies NA; Pandya A
    Value Health; 2017; 20(7):894-901. PubMed ID: 28712618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical policies: effects of financial incentives for prescribers.
    Rashidian A; Omidvari AH; Vali Y; Sturm H; Oxman AD
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD006731. PubMed ID: 26239041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Getting Incentives Right in Payment Reform: Thinking Beyond Financial Risk.
    Rathi VK; McWilliams JM; Roberts ET
    Ann Intern Med; 2020 Mar; 172(6):423-424. PubMed ID: 32066143
    [No Abstract]   [Full Text] [Related]  

  • 20. Reporting quality in merit-based incentive payment system year 3.
    Smolock C; Ciocca RG; Woo K; Rathbun J; Ryan P
    J Vasc Surg; 2019 Jun; 69(6):1999. PubMed ID: 31159992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.